| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Hormone Research |
| Vol/bind | 51 |
| Sider (fra-til) | 141-148 |
| Antal sider | 7 |
| ISSN | 0301-0163 |
| Status | Udgivet - 1999 |
FN’s Verdensmål
Dette resultat bidrager til følgende verdensmål
determination of insulin-like growth factor-I in the monitoring of GH treatment with respect to effiicacy and side effects. Should potential risks of cardiovascular disease and cancer be considered?
15
Citationer
(Scopus)
